Target intelligence / Profile preview

Riboflavin kinase pseudogene 1 (RFKP1)

Target
RFKP1
Molecular classification
Pseudogene
01

Overview

Riboflavin kinase pseudogene 1 (RFKP1) is an annotated human pseudogene related by sequence to riboflavin kinase enzymes, which are responsible for the phosphorylation of riboflavin (vitamin B2) to form flavin mononucleotide (FMN) as part of cellular metabolism[1][4][9]. However, RFKP1 does not encode a functional enzyme or protein; it is a non-functional genetic relic, often arising from duplication or mutation events that disable the original coding sequence. Consequently, RFKP1 is not expressed as an active protein and does not contribute to metabolic processes or serve as a therapeutic target. Pseudogenes such as RFKP1 may appear in genomic analyses but are excluded from consideration for drug discovery and disease association unless they acquire novel regulatory roles or are misannotated[1][4][9]. Other riboflavin kinase proteins (related, but NOT RFKP1) are active enzymes (e.g., RFK) with important metabolic, disease, and drug relevance[7][8], but this does not apply to RFKP1. RFKP1 is not a canonical drug target, does not code for a functional molecule, and its inclusion in therapeutic target lists would be considered a misannotation or error[1][4][9].

Other names
Riboflavin kinase pseudogene 1RFKP1

Beyond the preview

Go deeper on Riboflavin kinase pseudogene 1 (RFKP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Riboflavin kinase pseudogene 1 (RFKP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call